In Russia, birch bark has found a new use – they began to make a medicine from it for prevention
It is known that at the moment the secondphase of clinical trials of the drug "Betukladin", created by Yakut scientists. This was announced by its developer, chief researcher at the Institute for Biological Problems of Permafrost of the Siberian Branch of the Russian Academy of Sciences Boris Kershengolts.
It is noted that clinical trials"Betukladina" were held three years ago. Then the drug showed itself well as a dietary supplement in the treatment of multidrug-resistant pulmonary tuberculosis, as well as hepatitis B+D. At the end of last year, in turn, the second stage of clinical trials for its effectiveness against coronavirus ended.